CNBC's Joe Kernen reports on the latest news.
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
CNBC's Angelica Peebles joins 'The Exchange' to discuss President Trump posting letters to 17 pharmaceutical companies about drug prices.
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Besides Wall Street's top-and-bottom-line estimates for Pfizer (PFE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart

Where Will Pfizer (PFE) Be in 5 Years?

04:51am, Thursday, 31'st Jul 2025
Five years ago, the eyes of the world were on Pfizer (PFE -2.00%). The big drugmaker was racing to develop a COVID-19 vaccine with its partner, BioNTech (BNTX -1.41%).
As a newish investor, I used to get my head turned all the time by the next exciting growth stock. Growth stocks can be great, and more than a few of them have helped my portfolio grow well.

2 Dividend Stocks Yielding Over 7% to Buy

12:27pm, Tuesday, 29'th Jul 2025
PFE and CAG are two standout 7%-yielders that have relatively safe payouts. Headwinds facing both firms are tremendous, but there's already so much negativity priced in at these depths.
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
You'd think that companies with long, successful track records and market caps in the hundreds of billions of dollars would be viewed as relatively formidable. However, that's not always the case.

Keep Calm And Keep Buying These Dividends

11:30am, Saturday, 26'th Jul 2025
Dividend investing has lagged growth stocks recently. When combined with sustained headwinds for the sector, it can be tempting to give up on dividend investing and chase the hot stocks instead. I sha

Pfizer's Comeback Is Underway

10:47am, Friday, 25'th Jul 2025
Pfizer's $7.7B cost-savings plan is boosting margins and EPS, offsetting COVID revenue declines and patent cliff concerns. Core business is growing 12% ex-COVID, with strength in oncology, vaccines, a
Graham All Star Value (GASV) strategy identifies top dividend 'dogs' offering high yield and fair pricing, using YCharts' large cap value and Ben Graham screens. Analyst projections suggest the top te
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE